Northwire Canada EditionFriday, July 10, 2026
Northwire
AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.67 +3.7% SGZ 0.040 −11.1% GRSL 0.310 −3.1% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.67 +3.7% SGZ 0.040 −11.1% GRSL 0.310 −3.1%
Financings

Atmofizer & Power Leaves Corp. Enter Into LOI for RTO; Target Public Listing in H1 2026

ATMO · Price

Executive Summary

  • Atmofizer Technologies Inc. and Power Leaves Corp. have signed a non‑binding LOI for Atmofizer to acquire all outstanding securities of PLC in a reverse‑takeover transaction, creating the combined entity “Power Leaves Holdings Corp.”
  • The proposed transaction is expected to close by end‑June 2026, subject to CSE approval and execution of a definitive agreement by 20 Mar 2026.
  • Prior to closing, PLC will conduct a concurrent financing of up to US$3 million via subscription receipts priced at US$0.25 each, issuing units consisting of one common share and one warrant (US$0.30 exercise price, 24‑month term).

Key Details

  • Transaction Structure: Reverse takeover – Atmofizer acquires all PLC securities; resulting issuer will continue PLC’s business under a new name.
  • Closing Timeline: Expected before end of June 2026; definitive agreement to be signed by 20 Mar 2026.
  • Fundamental Change: Transaction triggers a “Fundamental Change” under CSE policies; post‑closing shares anticipated to list on the CSE.
  • Share Exchange Ratio: PLC securities will be exchanged for equivalent securities of the resulting issuer; Atmofizer shares may be consolidated or split at a ratio determined immediately before closing.
  • Board Composition: Resulting issuer’s board to consist of five directors, all nominated by PLC.
  • Concurrent Financing Terms:
  • Gross proceeds up to US$3 million (or other amount as determined).
  • Subscription receipts priced at US$0.25 each.
  • Each receipt converts into one unit: one common share + one whole warrant (exercise price US$0.30, exercisable for 24 months from listing date).
  • Net proceeds earmarked for scaling production capacity, implementing quality systems/certifications, working capital, and general corporate purposes.
  • Escrow & Lock‑up Conditions:
  • PLC founders/principals acquiring shares below certain price thresholds must lock up shares for 12 months.
  • Certain Atmofizer shareholders to agree to lock‑ups on their shares (terms to be agreed).
  • Legal Advisors: Wildeboer Dellelce LLP (PLC) and Gowling WLG (Canada) LLP (Atmofizer).
  • Forward‑Looking Statements: The release contains numerous forward‑looking statements regarding completion of the transaction, financing, listing, and approvals; no assurance that the proposed transaction will be completed.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Atmofizer Technologies Inc.